27.05.2020

Swiss TPH Supports COVID-19 Efforts through Swiss Government Funding

The Swiss Agency for Development and Cooperation (SDC) is supporting the re-allocation of funds within existing projects that are implemented by Swiss TPH in Africa, Central Asia... More...

14.05.2020

Molecular Signatures can Predict the Efficacy of Malaria Vaccines

A new study reveals that it is possible to identify those individuals that will be protected by the malaria vaccine before its administration. The researchers also found that... More...

13.05.2020

Swiss TPH Is Awarded Three New Grants from the Botnar Research Centre for Child Health to Combat COVID-19

Swiss TPH has been awarded 3 out of 11 new research grants from the Fast Track Call for Acute Global Health Challenges put forward by the Botnar Research Centre for Child Health... More...

11.05.2020

10 Years Swiss TPH: Integration of the ISPM into the Former Swiss Tropical Institute

Ten years ago, the former Institute of Social and Preventive Medicine (ISPM) within the University of Basel’s Faculty of Medicine was integrated into the Swiss Tropical Institute... More...

06.05.2020

"It Is a Race Against Time." An Interview with Claudia Daubenberger on Establishing a Diagnostic Lab for Sars-CoV-2 in Equatorial Guinea

COVID-19 poses major challenges for resource-limited countries, also when it comes to diagnostics. Swiss TPH is supporting Equatorial Guinea in establishing one of the few... More...

26.04.2020

Epidemiologist and Health Expert Marcel Tanner Receives Honorary Doctorate from the University of Zurich

Marcel Tanner is one of the most distinguished health experts in Switzerland. His contributions in the fields of global health, infection biology and malaria research and the... More...

25.04.2020

World Malaria Day 2020: Urgent Action Is Critical to Save Lives

This year's World Malaria Day is marked by major advances in the fight against malaria, with more than 7 million lives saved and over 1 billion cases prevented in the last two... More...

23.04.2020

Trial Launched to Test Prophylactic Treatments for COVID-19 Contact Persons

With the easing of measures, there is a pressing need for tools and approaches to contain potential new COVID-19 outbreaks. Academic partners in Geneva and Basel joined forces to... More...

17.04.2020

Sleeping Sickness Elimination at a Crossroads

Human African trypanosomiasis, also known as HAT or sleeping sickness, is a vector-borne parasitic disease. Since the number of new cases reported between 2000 and 2018 dropped by... More...